-+ 0.00%
-+ 0.00%
-+ 0.00%

LYNCH REGENERATIVE MEDICINE ANNOUNCES COMPLETION OF ENROLLMENT IN A PHASE II CLINICAL TRIAL EVALUATING RHPDGF-BB IN THE RECONSTRUCTION OF FULL-THICKNESS HEAD OR NECK DEFECTS FOLLOWING SKIN CANCER EXCISION

Reuters·08/18/2026 12:45:23

Please log in to view news